Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ANGIODYNAMICS, INC.

(ANGO)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Insider Trends: AngioDynamics Insider Gets Shares Award Makes Tax Sale with Portion, Easing 90-Day Buy Trend

07/23/2021 | 06:45pm EDT


ę MT Newswires 2021
All news about ANGIODYNAMICS, INC.
09/15ANGIODYNAMICS : to Report Fiscal 2022 First Quarter Financial Results on Septemb..
BU
08/30ANGIODYNAMICS : New AMA Category III CPT Code Issued for Transcatheter Removal/D..
PU
08/20ANGIODYNAMICS : Oppenheimer Initiates Coverage on AngioDynamics With Perform Rat..
MT
08/17INSIDER TRENDS : Insider at AngioDynamics Acquires Stock Via Conversion of Optio..
MT
08/12ANGIODYNAMICS : Receives FDA Approval for PRESERVE Study
PU
07/29ANGIODYNAMICS : to Present at the Canaccord Genuity Virtual Growth Conference
BU
07/27ANGIODYNAMICS : Management's Discussion and Analysis of Financial Conditions and..
AQ
07/23INSIDER TRENDS : AngioDynamics Insider Gets Shares Award Makes Tax Sale with Por..
MT
07/14ANGIODYNAMICS : Canaccord Genuity Adjusts Price Target on AngioDynamics to $28 F..
MT
07/13ANGIODYNAMICS : rsquo; Fiscal 2021 Fourth Quarter Financial Results
PU
More news
Analyst Recommendations on ANGIODYNAMICS, INC.
More recommendations
Financials (USD)
Sales 2022 308 M - -
Net income 2022 -15,2 M - -
Net Debt 2022 - - -
P/E ratio 2022 -65,5x
Yield 2022 -
Capitalization 973 M 973 M -
Capi. / Sales 2022 3,16x
Capi. / Sales 2023 2,93x
Nbr of Employees 800
Free-Float 95,6%
Chart ANGIODYNAMICS, INC.
Duration : Period :
AngioDynamics, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ANGIODYNAMICS, INC.
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 4
Last Close Price 25,31 $
Average target price 30,00 $
Spread / Average Target 18,5%
EPS Revisions
Managers and Directors
James Christopher Clemmer President, Chief Executive Officer & Director
Stephen A. Trowbridge Chief Financial Officer & Executive Vice President
Howard W. Donnelly Independent Non-Executive Chairman
David D. Helsel SVP-Global Operations, Research & Development
Kim L. Seabury Senior Vice President-Information Technology
Sector and Competitors